SITAGLIPTIN AND METFORMIN SANDOZ (Sandoz Pty Ltd)
Product name
SITAGLIPTIN AND METFORMIN SANDOZ
Sponsor
Date registered
Evaluation commenced
Decision date
Approval time
148 (255 working days)
Active ingredients
metformin hydrochloride; sitagliptin hydrochloride monohydrate
Registration type
New generic medicine
Indication
SITAGLIPTIN AND METFORMIN SANDOZ (as hydrochloride monohydrate) and metformin hydrochloride (film coated tablet) is indicated as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes mellitus when treatment with both sitagliptin and metformin is appropriate.